Clinical Trials Logo

Clinical Trial Summary

CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.


Clinical Trial Description

The long-term safety of TRTP-101 was evaluated by participants in the CIC101-01 clinical trial and followed up for 5 years for serious adverse events. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06435884
Study type Observational
Source CellinCells
Contact HyeJung Park, Director
Phone 82-70-4469-9115
Email hjpark@cellincells.com
Status Not yet recruiting
Phase
Start date September 2024
Completion date December 2029

See also
  Status Clinical Trial Phase
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Recruiting NCT05936437 - Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment N/A
Active, not recruiting NCT04519515 - Vollure for the Correction of Atrophic Facial Scarring N/A
Not yet recruiting NCT06298591 - The Efficacy of Combination Therapy in Atrophic Scars N/A
Completed NCT03264573 - Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars N/A
Not yet recruiting NCT05695807 - Carboxytherapy in the Treatment of Atrophic Scars N/A
Recruiting NCT06210919 - Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars Phase 1
Completed NCT05686603 - Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar N/A